Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Wilms Tumor”

259 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 259 results

Not applicableStudy completedNCT01550393
What this trial is testing

Biomarkers in Urine Samples From Patients With Wilms Tumor

Who this might be right for
Kidney Cancer
Children's Oncology Group 100
Early research (Phase 1)Study completedNCT01222780
What this trial is testing

To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer

Who this might be right for
SarcomaNeuroblastomaWilms Tumor+3 more
Acrotech Biopharma Inc. 22
Large-scale testing (Phase 3)UnknownNCT00047138
What this trial is testing

Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor

Who this might be right for
Kidney Cancer
University of Leicester 350
Early research (Phase 1)Study completedNCT01842139
What this trial is testing

Vaccine Therapy and Basiliximab in Treating Patients With Acute Myeloid Leukemia in Complete Remission

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+4 more
University of Chicago 7
Early research (Phase 1)Study completedNCT01621542
What this trial is testing

Clinical Study of WT2725 in Patients With Advanced Malignancies

Who this might be right for
Cancer
Sumitomo Pharma America, Inc. 64
Post-approval studies (Phase 4)Study completedNCT00336531
What this trial is testing

Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation

Who this might be right for
NeuroblastomaBrain TumorRetinoblastoma+2 more
Samsung Medical Center 100
Early research (Phase 1)Study completedNCT00931931
What this trial is testing

HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors

Who this might be right for
RhabdomyosarcomaOsteosarcomaEwing Sarcoma+6 more
Timothy Cripe 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT03213652
What this trial is testing

Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmMalignant Solid NeoplasmRecurrent Ependymoma+30 more
National Cancer Institute (NCI) 13
Early research (Phase 1)Study completedNCT01169584
What this trial is testing

Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients

Who this might be right for
NeuroblastomaRhabdomyosarcomaLymphoma+2 more
Jennerex Biotherapeutics 6
Testing effectiveness (Phase 2)Study completedNCT00488592
What this trial is testing

Peptide Vaccinations to Treat Patients With Low-Risk Myeloid Cancers

Who this might be right for
Myelodysplastic Syndrome (MDS)Acute Myeloid Leukemia (AML)Chronic Myeloid Leukemia (CML)
National Heart, Lung, and Blood Institute (NHLBI) 10
Large-scale testing (Phase 3)UnknownNCT00003804
What this trial is testing

Chemotherapy Plus Surgery in Treating Children at Risk of or With Stage I Wilms' Tumor

Who this might be right for
Kidney Cancer
University of Leicester 350
Large-scale testing (Phase 3)Active Not RecruitingNCT00945009
What this trial is testing

Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor

Who this might be right for
Adult Kidney Wilms TumorBeckwith-Wiedemann SyndromeChildhood Kidney Wilms Tumor+7 more
Children's Oncology Group 249
Early research (Phase 1)Study completedNCT01440920
What this trial is testing

A Phase I Study of OCV-501 in Acute Myeloid Leukemia Patients

Who this might be right for
Acute Myeloid Leukemia
Otsuka Pharmaceutical Co., Ltd. 9
Testing effectiveness (Phase 2)Study completedNCT00405327
What this trial is testing

A Pilot Study of Tumor Cell Vaccine for High-risk Solid Tumor Patients Following Stem Cell Transplantation

Who this might be right for
SarcomaNeuroblastomaWilm's Tumor
University of Michigan Rogel Cancer Center 16
Testing effectiveness (Phase 2)UnknownNCT05199584
What this trial is testing

A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations

Who this might be right for
Solid Tumors With PTCH1 Loss-of-function Mutations
Endeavor Biomedicines, Inc. 44
Not applicableWithdrawnNCT00624962
What this trial is testing

Early Enteral Tube Feedings in Children Receiving Chemo for AML/MDS & High Risk Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsKidney CancerLeukemia+4 more
Vanderbilt University
Testing effectiveness (Phase 2)Ended earlyNCT03311334
What this trial is testing

DSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Solid Tumors

Who this might be right for
Renal Cell Carcinoma (RCC)Urothelial CarcinomaPrimary Peritoneal Cancer+3 more
Sumitomo Pharma America, Inc. 47
Large-scale testing (Phase 3)Study completedNCT03149003
What this trial is testing

DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy

Who this might be right for
Glioblastoma
Sumitomo Pharma America, Inc. 221
Testing effectiveness (Phase 2)Ended earlyNCT02624388
What this trial is testing

Study of Genistein in Pediatric Oncology Patients (UVA-Gen001)

Who this might be right for
LymphomaChildhood LymphomaSolid Tumor+13 more
University of Virginia 4
Testing effectiveness (Phase 2)Looking for participantsNCT05135975
What this trial is testing

Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

Who this might be right for
NeuroblastomaSarcoma
Nationwide Children's Hospital 86
Load More Results